Afatinib for Erlotinib Refractory Brain Metastases in a Patient with EGFR-Mutant Non–Small-Cell Lung Cancer: Can High-Affinity TKI Substitute for High-Dose TKI?

No abstract available
Source: Journal of Thoracic Oncology - Category: Cancer & Oncology Tags: Letters to the Editor Source Type: research